DM001

· Xadcera Biopharmaceutical (Suzhou) Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DM001, covering 2025-04-17 to 2025-04-17. Get the full timeline:

Most recent: Clinical Trial Update: A Study of DM001 in Patients With Advanced Solid Tumors [Phase 1]